EBITDA Summary of Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology CO., LTD.'s latest annual EBITDA in 2023 was 345.42 Million CNY , down -15.45% from previous year.
Jinhe Biotechnology CO., LTD.'s latest quarterly EBITDA in 2024 Q3 was 88.43 Million CNY , up 176.27% from previous quarter.
Jinhe Biotechnology CO., LTD. reported an annual EBITDA of 284.6 Million CNY in 2022, up 0.93% from previous year.
Jinhe Biotechnology CO., LTD. reported an annual EBITDA of 357.58 Million CNY in 2021, up 5.75% from previous year.
Jinhe Biotechnology CO., LTD. reported a quarterly EBITDA of 88.43 Million CNY for 2024 Q3, up 176.27% from previous quarter.
Jinhe Biotechnology CO., LTD. reported a quarterly EBITDA of 74.12 Million CNY for 2024 Q1, up 67.03% from previous quarter.

Annual EBITDA Chart of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Historical Annual EBITDA of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Year	EBITDA	EBITDA Growth
2023	345.42 Million CNY	-15.45%
2022	284.6 Million CNY	0.93%
2021	357.58 Million CNY	5.75%
2020	326.9 Million CNY	-19.16%
2019	380.96 Million CNY	16.79%
2018	330.91 Million CNY	29.41%
2017	258.31 Million CNY	-10.88%
2016	297.87 Million CNY	45.25%
2015	210.36 Million CNY	49.09%
2014	142.66 Million CNY	-6.26%
2013	148.22 Million CNY	-6.7%
2012	160.76 Million CNY	6.89%
2011	145.73 Million CNY	30.42%
2010	114.18 Million CNY	52.38%
2009	77.19 Million CNY	94.92%
2008	38.88 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	32.01 Million CNY	-56.81%
2024 Q3	88.43 Million CNY	176.27%
2024 Q1	74.12 Million CNY	67.03%
2023 Q2	78.66 Million CNY	43.7%
2023 Q1	54.74 Million CNY	349.26%
2023 FY	- CNY	-15.45%
2023 Q4	-47.39 Million CNY	-218.91%
2023 Q3	39.85 Million CNY	-49.34%
2022 Q4	12.18 Million CNY	-72.66%
2022 FY	- CNY	0.93%
2022 Q3	44.57 Million CNY	-48.71%
2022 Q2	86.89 Million CNY	41.57%
2022 Q1	61.37 Million CNY	71.59%
2021 FY	- CNY	5.75%
2021 Q2	62.05 Million CNY	-36.53%
2021 Q3	29.92 Million CNY	-51.78%
2021 Q1	97.76 Million CNY	127.85%
2021 Q4	35.76 Million CNY	19.55%
2020 Q2	68.08 Million CNY	-18.53%
2020 Q1	83.57 Million CNY	-11.23%
2020 Q4	42.9 Million CNY	81.2%
2020 FY	- CNY	-19.16%
2020 Q3	23.67 Million CNY	-65.22%
2019 Q2	100.73 Million CNY	62.8%
2019 FY	- CNY	16.79%
2019 Q4	94.13 Million CNY	48.25%
2019 Q3	63.49 Million CNY	-36.96%
2019 Q1	61.87 Million CNY	-20.4%
2018 Q2	56.7 Million CNY	-18.82%
2018 Q1	69.85 Million CNY	86.46%
2018 Q4	77.73 Million CNY	14.4%
2018 FY	- CNY	29.41%
2018 Q3	67.94 Million CNY	19.82%
2017 Q4	37.46 Million CNY	-20.38%
2017 Q2	64.28 Million CNY	0.76%
2017 FY	- CNY	-10.88%
2017 Q1	63.79 Million CNY	-25.43%
2017 Q3	47.05 Million CNY	-26.81%
2016 Q4	85.56 Million CNY	102.27%
2016 FY	- CNY	45.25%
2016 Q3	42.3 Million CNY	-29.06%
2016 Q2	59.63 Million CNY	-16.99%
2016 Q1	71.83 Million CNY	25.59%
2015 Q2	45.8 Million CNY	34.7%
2015 Q1	34 Million CNY	25.72%
2015 FY	- CNY	49.09%
2015 Q4	57.19 Million CNY	105.69%
2015 Q3	27.8 Million CNY	-39.29%
2014 Q4	27.04 Million CNY	49.39%
2014 FY	- CNY	-6.26%
2014 Q2	36.23 Million CNY	55.42%
2014 Q1	23.31 Million CNY	-27.93%
2014 Q3	18.1 Million CNY	-50.03%
2013 Q3	23.69 Million CNY	-30.07%
2013 Q4	32.34 Million CNY	36.53%
2013 FY	- CNY	-6.7%
2013 Q1	23.69 Million CNY	-43.24%
2013 Q2	33.88 Million CNY	43.0%
2012 Q2	36.18 Million CNY	3.6%
2012 Q4	41.74 Million CNY	232.16%
2012 Q1	34.93 Million CNY	-3.29%
2012 Q3	12.56 Million CNY	-65.27%
2012 FY	- CNY	6.89%
2011 Q4	36.11 Million CNY	320.13%
2011 Q3	8.59 Million CNY	0.0%
2011 FY	- CNY	30.42%
2010 FY	- CNY	52.38%
2009 FY	- CNY	94.92%
2008 FY	- CNY	0.0%

Peer EBITDA Comparison of Jinhe Biotechnology CO., LTD.

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	344.094%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	11.126%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	77.563%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	89.525%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	-126.957%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	-455.493%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	81.611%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	94.333%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	80.723%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	-160.908%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	-366.504%
Dezhan Healthcare Company Limited	219.36 Million CNY	-57.468%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	-38.373%
Jiuzhitang Co., Ltd.	460.28 Million CNY	24.955%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	83.763%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	63.464%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	-292.571%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	0.768%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	23.88%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	-143.928%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	-176.958%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	6.507%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	1207.202%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	406.372%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	75.125%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	-192.266%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	-107.575%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	-60.644%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	19.977%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	51.447%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	-264.547%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	34.702%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	247.859%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	-46.214%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	-2773.142%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	160.315%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	9.839%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	280.983%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	-4384.233%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	-292.749%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	-11.665%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	-79.401%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	568.958%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	68.472%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	20.634%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	9.292%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	17.286%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	885.158%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	50.377%
Tibet AIM Pharm. Inc.	50.76 Million CNY	-580.474%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	73.329%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	75.308%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	58.975%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	-15.086%
Xiamen Kingdomway Group Company	588.78 Million CNY	41.333%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	-171.847%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	63.184%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	77.67%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	-25.478%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	92.632%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	-23.074%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	-23.955%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	1.368%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	-158.679%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	71.13%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	-58.833%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	47.184%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	27.641%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	-352.636%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	93.418%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	25.562%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	7.969%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	43.4%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	93.367%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	-170.452%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	-50.905%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	-577.831%
Huadong Medicine Co., Ltd	4.61 Billion CNY	92.518%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	74.204%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	-88.073%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	-155.171%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	67.008%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	-847.775%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	-256.101%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	67.123%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	-174.476%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	60.019%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	207.915%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	215.677%

Global Stocks Search

Jinhe Biotechnology CO., LTD. (002688.SZ)

EBITDA Summary of Jinhe Biotechnology CO., LTD.

Annual EBITDA Chart of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Historical Annual EBITDA of Jinhe Biotechnology CO., LTD. (2023 - 2008)

Peer EBITDA Comparison of Jinhe Biotechnology CO., LTD.